Key takeaways Semaglutide is the active ingredient in Ozempic, an FDA-approved injection to lower blood sugar in the treatment of Type 2 diabetes and reduce cardiovascular and kidney risk in certain populations
Like Semaglutide, Tirzepatide is available as a weekly subcutaneous injection
Step 1: Consultation & Evaluation We sit down with you to understand your goals, challenges, eating patterns, stress levels, and overall health
Manage patient expectations by explaining to patients that once Wegovy is off the shortages list, cheaper compounded versions will likely become unavailable
Although generally well tolerated, semaglutide should not be taken by certain individuals: Anyone allergic to semaglutide or any inactive ingredients in the product Those with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Women who are pregnant or planning pregnancy (stop semaglutide at least 2 months before conception) Breastfeeding women (discuss risks if taking Wegovy or Ozempic
Hims announced in February that it would begin offering off-brand, compounded versions of Novo Nordisk's Wegovy
